Kaya Holdings (KAYS) Total Debt Growth (3y) (2014 - 2025)
Kaya Holdings (KAYS) Total Debt Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -7.03% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.29% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -58.89% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -12.80% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 72.82% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -4.66% |
| 10 | Kaya Holdings | - | - | 5,370.00 | -62.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -62.09% |
| Jun 30, 2025 | 41.60% |
| Mar 31, 2025 | -12.67% |
| Dec 31, 2024 | -40.12% |
| Mar 31, 2024 | 253.29% |
| Dec 31, 2023 | -44.52% |
| Sep 30, 2022 | 233.17% |
| Jun 30, 2022 | 104.59% |
| Mar 31, 2022 | 184.87% |
| Dec 31, 2021 | 262.56% |
| Dec 31, 2020 | 10.51% |
| Sep 30, 2019 | -48.14% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 37.03% |
| Sep 30, 2018 | -4.43% |
| Jun 30, 2018 | 232.46% |
| Dec 31, 2017 | 192.45% |
| Jun 30, 2017 | 151.66% |
| Dec 31, 2016 | 121.76% |
| Sep 30, 2016 | 29.59% |